1.0UEFConnecthttps://uefconnect.uef.fi/en/rich600338<blockquote class="wp-embedded-content" data-secret="vNXEZhLsIg"><a href="https://uefconnect.uef.fi/en/kirsi.ketola">Kirsi Ketola (kirsi.ketola@uef.fi)</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://uefconnect.uef.fi/en/kirsi.ketola/embed/#?secret=vNXEZhLsIg" width="600" height="338" title="“Kirsi Ketola (kirsi.ketola@uef.fi)” — UEFConnect" data-secret="vNXEZhLsIg" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://uefconnect.uef.fi/wp-includes/js/wp-embed.min.js /* ]]> */ </script> The Cancer Cell Plasticity research group investigates how prostate cancer cells adopt stem-like, neuroplastic, and neuroendocrine states to drive therapy resistance and disease progression. The group studies how cancer cells transition between cellular states in response to both therapeutic pressure and signals from the tumor microenvironment. These include immune cell–derived factors, neural and neuroendocrine-associated programs, […]